Stockscreener 앱 받기
10.84
0.09%
-0.010
전일 마감가:
$10.85
열려 있는:
$10.825
하루 거래량:
1,470
Relative Volume:
0.04
시가총액:
$263.16M
수익:
-
순이익/손실:
$6.66M
주가수익비율:
54.69
EPS:
0.1982
순현금흐름:
$-379.20K
1주 성능:
+0.00%
1개월 성능:
+0.74%
6개월 성능:
+3.24%
1년 성능:
+5.46%
1일 변동 폭
$10.82
$10.84
1주일 범위
$10.82
$10.85
52주 변동 폭
$10.26
$10.86
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
646-726-7074
주소
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, CCXI, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.84 | 263.16M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
10.85 | 3.23B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
6.64 | 2.30B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
24.05 | 1.20B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
12.43 | 692.35M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.16 | 647.19M | 0 | 8.58M | -1.11M | 0.134 |
Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스
Pfizer Inc. - Britannica
CATL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CATL PE Ratio & Valuation, Is CATL Overvalued - Intellectia AI
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Britannica
Catalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day - TradingView
HVMC Stock Price, Quote & News - Syfe
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Up 0.1%Here's What Happened - MarketBeat
DMAA resets Power Analytics merger at $2.85B fixed valuation - Dealroom
Drugs Made In America Restructures Merger with PAGC - TipRanks
Inside the $2.85B all-stock deal for DMAA (NASDAQ: DMAA) - Stock Titan
Drugs Made In America Acquisition Restates Merger With Power Analytics at $2.85 Billion Value - tradingview.com
EVOX Stock Price, Quote & News - Syfe
Affiliated (AMG) Flat at $356.19: Accumulation or Distribution Phase? 2026-09-10Regression Channel - dars.gov.et
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACFund Manager Survey - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
PURR Stock Price and Chart — NASDAQ:PURR - TradingView
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseSeasonality Effect - careplusvn.com
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilityQuality ETF - careplusvn.com
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
AstraZeneca falls to third-largest UK company amid US merger talks - theguardian.com
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsTPO Profile - careplusvn.com
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffCFO Commentary Report - careplusvn.com
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueIntraday Profile - careplusvn.com
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSentiment Shift - careplusvn.com
Arrow Financial Corporation Q2 2026 Earnings: EPS Surges 22% Above Estimates, Driving Modest GainsCEO Earnings Statement - careplusvn.com
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.15%
자본화:
|
볼륨(24시간):